Simplify Propel Opportunities ETF (SURI)

Overview

The fund described is an actively managed exchange-traded fund (ETF) that specializes in the health and life sciences sector. Concentrating its investments heavily within the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries, the fund adopts a strategy that involves investing more than 25% of its net assets in these areas. It operates under the guidance of a Sub-Adviser who executes an opportunistic multi-asset strategy. This approach allows for investment across a broad range of security types, including common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, as well as ETFs that majorly invest in similar types of securities. By design, this fund is non-diversified, aligning its focus on a more concentrated portfolio within the aforementioned sectors.

Products and Services

• Common Stock Investments

  The fund invests in the common stock of companies within the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. This encompasses equity stakes in businesses that are pioneering in medical research, drug development, and innovative health solutions.

• Preferred Stock Investments

  As part of its diversified approach, the fund also allocates assets in preferred stocks within the health and life science sector. Preferred stocks provide a potential advantage of fixed dividends, aligning with the fund's goal of achieving steady returns from its holdings in the healthcare industry.

• Convertible Bonds

  The investment strategy extends to convertible bonds issued by corporations within the targeted industries. These securities offer the fund the flexibility to convert debt into a predetermined number of common or preferred shares, typically at the discretion of the bondholder, which can be an attractive option during periods of stock market growth.

• Structured Notes

  Structured notes, combining bonds and additional derivatives, form a part of the fund’s portfolio. These are tailored to reflect the performance of specific securities, indexes, or commodities within the healthcare and life sciences sectors, offering unique risk-return profiles.

• Corporate Notes and Bonds

  Direct investments in corporate notes and bonds issued by companies within the fund's focus areas provide a stream of income through interest payments. This adds an element of fixed-income security to the fund’s investment strategy, balancing its overall risk.

• ETFs in Health and Life Sciences

  Finally, the fund allocates part of its assets to other ETFs that primarily invest in securities from the biotechnology, pharmaceutical, healthcare technology, and life science tools and services industries. This allows for enhanced diversification and access to a broader array of securities within the targeted sectors.